The temporal trajectory of platelet-derived growth factor (PDGF)-␤ receptor activation within the dorsocaudal brainstem parallels that of the mild hypoxic ventilatory depression (HVD) seen in adult rats. We hypothesized that enhanced PDGF-␤ receptor activity may account for the particularly prominent HVD of developing mammals. To study this issue, 2-, 5-, 10-, and 20-d-old rats underwent hypoxic challenges (10% O 2 for 30 min) after pretreatment with either vehicle (Veh) or the selective PDGF-␤ receptor antagonist CGP57148B (intraperitoneal 100 mg/kg). The developmental characteristics and magnitude of the peak hypoxic ventilatory response (HVR) were not modified by the PDGF-␤ receptor blocker. However, HVD was markedly attenuated by CGP57148B, and such effect, although still present, gradually abated with increasing postnatal age [p Ͻ 0.001, analysis of variance (ANOVA)]. Hypercapnic ventilatory responses were not affected by CGP57148B. The expression of PDGF-␤ receptor in the dorsocaudal brainstem was assessed by immunoblotting and confirmed progressively decreasing expression with maturation. We conclude that PDGF-␤ receptor activation during hypoxia is an important contributor to HVD at all postnatal ages but more particularly in the immature rat. The acute ventilatory response to hypoxia in adult mammalian species is biphasic. In the rat, after the initial ventilatory increase (which is primarily mediated by integration of peripheral chemoreceptor afferent input) there is a subsequent mild decrease in ventilation to levels that are lower than the peakearly ventilatory increase, although they exceed those during normoxia(1). In most neonatal mammals, however, this second phase of the HVR, also named HVD, is particularly prominent, and ventilation is usually reduced below normoxic levels (2). The mechanisms underlying HVD are complex and probably involve interaction of multiple neural pathways. In addition to decreases in oxygen consumption (3), GABA and adenosine release during hypoxia will further add to HVD, as will the relative paucity of nNOS expression within several brainstem nuclei mediating HVR (4 -7). Furthermore, several other mechanisms involving opioid receptors and local release of various neuroactive peptides have also been implicated in HVD (reviewed in ref. 8).
The acute ventilatory response to hypoxia in adult mammalian species is biphasic. In the rat, after the initial ventilatory increase (which is primarily mediated by integration of peripheral chemoreceptor afferent input) there is a subsequent mild decrease in ventilation to levels that are lower than the peakearly ventilatory increase, although they exceed those during normoxia (1) . In most neonatal mammals, however, this second phase of the HVR, also named HVD, is particularly prominent, and ventilation is usually reduced below normoxic levels (2) . The mechanisms underlying HVD are complex and probably involve interaction of multiple neural pathways. In addition to decreases in oxygen consumption (3), GABA and adenosine release during hypoxia will further add to HVD, as will the relative paucity of nNOS expression within several brainstem nuclei mediating HVR (4 -7) . Furthermore, several other mechanisms involving opioid receptors and local release of various neuroactive peptides have also been implicated in HVD (reviewed in ref. 8) .
In a recent study, we found that activation of PDGF-␤ receptors within the NTS modulated HVD in the adult freely behaving rat, as well as in the adult mouse. Indeed, pharmacological inhibition or diminished expression of PDGF-␤ re-ceptors within the dorsocaudal brainstem almost completely abolished the typical ventilatory decline that characteristically occurs with ongoing hypoxia (9) . In addition, we found that both PDGF-B chain and PDGF-␤ receptors, but not PDGF-␣ receptors, were abundantly expressed in a large proportion of NTS neurons undergoing functional recruitment during hypoxia and that acute hypoxia-induced PDGF-B chain mRNA transcription (9) . Although the mechanisms by which the PDGF-BB PDGF-␤ receptor system affects respiratory control are as yet unclear, we hypothesized that the developmental characteristics of HVD could be mediated at least in part by postnatal changes in PDGF-␤ receptor expression and/or function. In other words, the more pronounced HVD in the neonatal rat would be associated with higher expression of PDGF-␤ receptor within the dorsocaudal brainstem.
METHODS

Animals.
The experimental protocols were approved by the Institutional Animal Use and Care Committee and are in close agreement with the National Institutes of Health guide for the care and use of laboratory animals. All efforts were made to minimize animal suffering, reduce the number of animals used, and use alternatives to in vivo techniques. Time-pregnant Sprague-Dawley rats were obtained from a commercial breeder (Charles River Laboratories, Wilmington, MA, U.S.A.), and delivery times were recorded.
Ventilatory responses to hypoxia and hypercapnia. For hypoxic ventilatory studies, rat pups were randomly selected from every litter at postnatal d 2, 5, 10, and 20 (n ϭ 10 per age group). These ages have been previously shown as representative of maturational changes in the biphasic ventilatory response to hypoxia (2, 7) . Additional rat pups (n ϭ four per age group) underwent hypercapnic ventilatory challenges. For these experiments, as well as for the expression experiments delineated below, a total of 236 pups were used from 22 litters. Litters were routinely reduced to 12 pups by randomly euthanizing excess animals at birth with a pentobarbital overdose. For all experiments, similar numbers of male and female pups were used (120 males and 116 females).
Ventilatory recordings. Respiratory measures were continuously acquired in the freely behaving, unrestrained animal placed in a previously calibrated 0.5 L-Plexiglas™ chamber using whole-body plethysmography (Buxco Electronics, Troy, NY, U.S.A.) (10 -13) . To minimize the long-term effect of signal drift due to temperature and pressure changes outside the chamber, a reference chamber of equal size in which temperature was measured using a T-type thermocouple was used. In addition, a correction factor was incorporated into the software routine to account for inspiratory and expiratory barometric asymmetries (13) . Environmental temperature was maintained within 29 -32°C, which corresponds to usual environmental temperatures recorded in the nest. A calibration volume of 0.1 mL of air was repeatedly introduced into the chamber before and upon completion of recordings. At least 30 min before the start of each protocol, animals were allowed to acclimate to the chamber, in which humidified air (90% relative humidity) warmed at 30°C was passed through at a rate of 1 L.min Ϫ1 using a precision flow pump-reservoir system. Pressure changes in the chamber due to the inspiratory and expiratory temperature changes were measured using a high-gain differential pressure transducer (Validyne, Model MP45-1, Northridge, CA, U.S.A.). Analog signals were continuously digitized and analyzed on-line by a microcomputer software program (Buxco Electronics). A rejection algorithm was included in the breath-by-breath analysis routine and allowed for accurate rejection of motion-induced artifacts. VT, f, and V E were computed and stored for subsequent off-line analysis.
Protocol. Ventilatory challenges with 10% O 2 in N 2 lasting for 30 min were initially performed in each rat pup after intraperitoneal administration of Veh (0.2 mL of normal saline). Gas switches were performed by rapidly bleeding the premixed gas mixture into the recording chamber. Animals were allowed to recover with their mother in room air for 24 h and were then injected with the selective PDGF-␤ receptor antagonist, CGP 57148B (100 mg/kg intraperitoneal in 0.2 mL) (14) . Thirty min after CGP 57148B administration, hypoxic challenges were repeated. In a subset of three animals per age group, challenges were repeated after a second dose of normal saline to ascertain reproducibility and variability of the response at various postnatal ages. The adequacy of the CGP 57148B dosages and experimental time frames has been previously validated (9) . In brief, the dose of CGP 57148B was selected from a dose-response curve in the adult rat, as well as by doubling the dose of CGP 57148B, leading to maximal reduction of tyrosine phosphorylation of the receptor during hypoxic conditions (9) . For hypercapnic ventilatory challenges, 5% CO 2 balance room air was administered for 30 min after the same experimental template as that described for hypoxic runs. This time frame provides adequate expression of HVD and does not modify the ventilatory response to a subsequent challenge (7, 15, 16) .
Immunoblotting of PDGF-␤ receptor. Pooled dorsocaudal brainstem tissues (n ϭ five or six animals per sample), primarily corresponding to the NTS, were harvested at each postnatal age and from adult rats by punch sampling using a 17-gauge thin-walled hypodermic needle, as previously described (17) . Six separate experiments corresponding to a total of 42-48 animals per postnatal age were conducted. Samples were homogenized in lysis buffer (PBS pH 7.6, 0.5% sodium deoxycholate, 1% Nonidet P40, 0.1% SDS, 20 mM sodium orthovanadate, 10 g/mL aprotinin, 10 g/mL leupeptin, and 0.5 mM PMSF). Crude synaptosomes were obtained by centrifugation of the homogenates for 10 min at 1000 g and further centrifugation of supernatants at 15,000 g for 30 min. The resultant pellets were resuspended and assayed for protein content (Bio-Rad, Hercules, CA, U.S.A.). Five-hundred g of protein were used for the immunoprecipitation of PDGF-␤ receptor protein and incubated overnight at 4°C with 12 g of PDGF-␤ receptor antibody (UBI, Lake Placid, NY, U.S.A.) in a total volume of 500 L, after which 30 L of protein A Sepharose were added and incubated for 1 h at 4°C. The immunoprecipitates were washed three times with lysis buffer and resuspended in a mixture of 20 L lysis buffer and 20 L SDS-sample buffer (0.5 M Tris, pH 6.5, 20% glycerol, 4% SDS, 100 mM DTT). Proteins were separated by electrophore-237 sis on a 4% to 12% Tris-glycine gradient gel (Novex, San Diego, CA, U.S.A.), and transferred to a 0.2-m nitrocellulose membrane. Nonspecific binding was blocked by 1-h incubation with 5% BSA in TBS-T. The membrane was incubated overnight at 4°C with PDGF-␤ receptor antibody (1:300; UBI). Membranes were washed with TBS-T and incubated with secondary antibodies for 1 h. After extensive washing, proteins were detected by enhanced chemiluminescence (Amersham, Arlington Heights, IL, U.S.A.).
Data analysis. Values are reported as mean Ϯ SEM unless indicated otherwise. Baseline ventilation before each hypoxic run was defined as the average of ventilatory measures during the 3-min period immediately preceding the gas switch. For ventilatory challenges, mean V E values over a 1-min period were calculated and the peak average V E value over 1 min throughout the hypoxic run was considered as representative of the HVR. To normalize across the various postnatal ages, the overall peak V E increase during hypoxia was calculated using the normoxic baseline preceding each challenge and was therefore expressed as percent baseline. Similarly, the lowest average V E measured over a 1-min period was defined as corresponding to HVD. Again, to normalize across ages, HVD was calculated as percent baseline.
For western blot procedures, semiquantitative analysis of the bands was performed by scanning densitometry. Comparisons across treatment groups of numerical data were performed using either t tests or two-way ANOVA (treatment and time, or hypoxia/hypercapnia) followed by Newman-Keuls post hoc tests, as appropriate. A p value of Ͻ0.05 was considered to achieve statistical significance.
RESULTS
Ventilatory measurements.
Mean weights and baseline ventilatory measures for the four postnatal ages are shown in Table 1 .
In all pretreated animals, an initial V E increase occurred with the hypoxic stimulus onset and was considered to primarily represent peripheral chemoreceptor contributions (Figs. 1 and  2 ). As previously shown (2, 7, 15, 16) , an age-dependent increase in the magnitude of the HVR was apparent. However, the magnitude of HVR was unchanged by pretreatment with CGP 57148B (Figs. 1 and 2) , and no changes in either f or VT occurred when Veh and CGP 57148B were compared (p ϭ NS). Similarly, CGP 57148B did not affect respiratory drive (VT/Ti) or timing (Ti/TTOT). Taken together, these data suggest that PDGF-␤ receptor inhibition does not modify peripheral chemoreceptor-mediated responses at any postnatal age.
A significant ventilatory decline from the early-peak V E response occurred in all developing animals over time, such that by 30 min into the hypoxic challenge V E had decreased below room air values in 2-, 5-, and 10-d-old rat pups (Figs. 1   and 3 ). In 20-d-old rat pups, late hypoxic ventilatory measurements remained 17.8 Ϯ 7.2% above room-air baseline (p Ͻ 0.01 versus any other rat pup group). Thus, with increasing postnatal age, the magnitude of the biphasic ventilatory response to hypoxia was diminished (p Ͻ 0.02, two-way ANOVA).
In CGP 57148B-treated conditions, HVD was markedly attenuated in the youngest animals ( Figs. 1 and 3) , and although this attenuation was present at all postnatal ages, the magnitude of CGP 57148B effect on HVD diminished with increasing postnatal age ( Figs. 1 and 3 ; p Ͻ 0.0001 ANOVA).
Although significant increases in overall ventilatory responses to hypercapnia occurred with advancing maturation, the magnitude of the ventilatory response to hypercapnia at any given postnatal age was similar in Veh-and CGP 57148B-treated animals ( Fig. 4; p ϭ NS) .
Immunoblots of PDGF-␤ receptor in the dorsocaudal brainstem. Western blotting of protein equivalents from tissue homogenates derived from pooled dorsocaudal brainstem tissue at various postnatal ages revealed decreasing PDGF-␤ receptor expression with maturation ( Fig. 5 ; n ϭ 6; p Ͻ 0.003 ANOVA).
DISCUSSION
This study shows that with increased maturation there is decreasing expression of PDGF-␤ receptor within the dorsocaudal brainstem, and that these postnatal changes in receptor expression are intimately associated with their modulatory (2), and our previous findings (7) . Indeed, significant enhancements of the peak V E response and reduced HVD occurred with increasing postnatal age (2, 7). Because hypoxia induces significant reductions in oxygen consumption (V O2 ) (18), we attempted to partially circumvent this problem by maintaining environmental temperature near the thermoneutral range during ventilatory measurements. However, it is unlikely that the PDGF-␤ receptor inhibitor modified metabolic rates or thereby significantly affected our results. Indeed, CGP 57148B did not alter the magnitude of the peak V E response, and the latter should have been increased if CGP 57148B had increased metabolic rates. In addition, because thermal conditions were similar before and after CGP 57148B administration, it is unlikely that differences in ventilatory measurements resulted from hypoxia-induced V O2 changes. Nonetheless, one cannot exclude with certainty the possibility that intraperitoneal administration of a selective PDGF-␤ receptor blocker such as CGP 57148B may have affected metabolic rates, because the time course and metabolic consequences of such inhibitors in developing animals during normoxia and hypoxia are currently unknown.
Table 1. Mean (Ϯ SEM) baseline ventilatory and weight measurements in 2-, 5-, 10-, and 20-d-old rat pups
A substantial body of evidence supports a major role for brainstem glutamatergic mechanisms in the V E enhancements that accompany application of a hypoxic stimulus (19) . However, whereas glutamate receptors are critical to HVR in the adult rat (20, 21) , their contribution emerges as much more modest in the neonatal rat (15, 16) . Although reduced expression of glutamate receptors within some of the caudal brainstem regions involved in HVR may certainly play a role in the developmental characteristics of HVR, it is clear that after the peak excitatory ventilatory effects of hypoxia have occurred, HVD will emerge rather rapidly in the immature rat. From our current experiments, it does not appear that a tonic inhibitory effect of PDGF-␤ receptor activity was present on these excitatory pathways, as pretreatment with CGP 57148B failed to modify the characteristics of HVR at any postnatal age. Thus, the effect of PDGF-␤ receptor activity appears to directly involve the generation of HVD rather than indirectly affect the magnitude and temporal characteristics of HVR.
The mechanism underlying such direct effect on HVD is unknown. However, one potential mechanism could involve functional interactions between glutamate and PDGF-␤ receptors as proposed by Valenzuela and colleagues while studying the effect of the PDGF BB isoform on glutamate receptor function in hippocampal neurons (22) . These investigators proposed that activation of PDGF-␤ receptors would lead to downstream activation of a signaling cascade involving forma- 
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tion of phosphoinositol triphosphate. This in turn would lead to the undocking of glutamate receptor-activated PKC, which would down-regulate the inotropic current elicited by activation of the glutamate receptor (22) . Although the intracellular signaling pathways involved in glutamate receptor channelmediated ionic influxes during acute hypoxia are not yet fully characterized, we have previously ascribed important putative roles for nNOS, PKC, and tyrosine kinases (7, 17, (23) (24) (25) (26) (27) (28) (29) (30) . Furthermore, we have shown that the activation of these signaling pathways is transient. Indeed, at time points corresponding to HVD the activities of both PKC and other kinases, such as c-Jun-N-terminal kinase, will have returned to near normoxic baseline values in the brainstem of adult rats (29, 31) . The transient nature of these events is compatible with the putative mechanisms proposed by Valenzuela et al. (22) and suggests that PDGF-␤ receptor activation could be implicated in the down-regulation of such HVR-related kinases in the brainstem.
How can we reconcile the aforementioned pathways that were identified in the adult with the patterning of HVD in the developing animal? First and foremost, we do not suggest that PDGF-␤ receptor activation is the only mechanism underlying HVD. In fact, HVD was attenuated but still present after administration of the PDGF-␤ receptor antagonist (Fig. 1) . Second, we have previously demonstrated that the paucity of nNOS expression in the brainstem of the developing rat precludes the ability to sustain increased ventilatory output during hypoxia (7) . Third, there are clearly other neurotransmitters implicated in HVD, such as GABA (5), adenosine (6) , and opioid receptors (8) . Finally, the immature rat displays increased dependency of ventilatory drive on PKC activity (32) . Thus, as previously proposed by Valenzuela et al. (22) , if one of the major effects linked to PDGF-␤ receptor activation consists in the down-regulation of PKC activity in glutamatergic HVR neurons, the present data could provide a plausible mechanism for the enhanced role of PDGF-␤ receptor on HVD in the youngest rats. In this context, higher expression and activity of PDGF-␤ receptor during hypoxia in these glutamatergic HVR neurons would lead to a more pronounced deactivation of PKC, and accordingly to enhanced reductions in ventilatory output.
Expression of PDGF-␤ receptors. Previous investigators have shown that both the PDGF-B chain and the PDGF-␤ receptor are widely expressed in CNS neurons of the monkey, albeit with heterotopic distribution, such that the hippocampus, hypothalamus, posterior pituitary, amygdala, and nuclei within the brainstem show the highest degree of immunostaining (33) . Furthermore, in transgenic mice in which the chloramphenicol acetyltransferase gene was placed under transcriptional control of the PDGF-B chain promoter, preferential expression occurred in the cortex, hippocampus, and brainstem, and was highest around birth, suggesting that PDGF-B is developmentally regulated (33) . Similar results showing increased PDGF-␤ receptor expression in the neonatal rat brain were reported by Smits and colleagues (34) , while the expression of PDGF-␣ receptors increases throughout E15 to P14 and then decreases with advancing age (35, 36) . Our current findings are in close agreement with previous studies, and extend such observations to the dorsocaudal brainstem, a brain region that plays a major role in the ventilatory response to hypoxia.
In summary, we present evidence indicating that the characteristically pronounced ventilatory reduction in response to sustained hypoxia, as measured in the developing rat, correlates with levels of PDGF-␤ receptor expression. However, activation of PDGF-␤ receptors does not seem to play a role in the early phase of the HVR or in the ventilatory response to hypercapnia. 
